-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
In studies in mice, the researchers found that the combination slowed tumor progression in multiple mouse models of colorectal cancer, and in some mice it led to disease regression
"We show for the first time how a completely nontoxic intervention can be effectively treated," said the study's corresponding author, Valter Longo, professor of geriatrics and biological sciences at the USC Longevity Institute.
While fasting remains a challenging option for cancer patients, a safer and more feasible option is a low-calorie, plant-based diet that allows cells to respond, the researchers said
Their findings suggest that a less toxic treatment, one that mimics fasting plus vitamin C, has the potential to replace the more toxic one
Previous studies on the anticancer effects of vitamin C have been inconsistent
"Our first in vitro experiments showed dramatic effects," Longo said
Longo and his colleagues found this strong effect only in KRAS-mutated cancer cells, which is considered one of the most challenging targets in cancer research
These mutations in the KRAS gene suggest that the body is resistant to most anti-cancer treatments, which reduces patient survival
The study also provides some clues as to why previous research on vitamin C as a potential anti-cancer therapy has shown limited effectiveness
On its own, vitamin C treatment appears to protect cancer cells by raising levels of ferritin, a protein that binds iron, triggering KRAS mutant cells
In this study, the scientists also found that colorectal cancer patients with high iron-binding protein levels had lower survival rates
"In this study, we observed how rapidly a dietary cycle mimicked the efficacy of vitamin C drug doses in KRAS-mutant cancers," said study co-author Maira Di Tano of the IFOM Molecular Oncology Research Center in Milan, Italy
Previous research by the research team has shown that fasting and fasting-mimicking diets can slow cancer progression, making chemotherapy more effective on tumor cells, while protecting normal cells from chemotherapy-related side effects
In mouse models of breast cancer and melanoma, the combination enhanced the immune system's antitumor response
Scientists believe that treating cancer will eventually use less toxic drugs, like antibiotics are used to treat infections that kill certain bacteria, but if the first drug doesn't work, other drugs can be substituted
To get there, they said, they needed to first test two hypotheses: Their drug-free combination intervention would work in mice and look promising in human clinical trials
At least five clinical trials, including one at the University of Southern California in breast and prostate cancer patients, are studying the effects of a simulated fasting diet combined with different cancer drugs
.
Maira Di Tano et al, Synergistic effect of fasting-mimicking diet and vitamin C against KRAS mutated cancers